2015 Annual Meeting W2114 :What ISUP with Prostate Cancer? Grading, Variants, and New Developments |
SUNDAY, JUNE 21, 0800-1130, W2114
Please take a few minutes of your time to evaluate the scientific sessions.
Please take a few minutes of your time to evaluate the scientific sessions.
David Berman, Queen’s Cancer Research Institute; Queen’s University
Theodorus Van Der Kwast, Toronto General Hospital;
Theodorus Van Der Kwast, Toronto General Hospital;
University Health Network
George Yousef, St. Michael’s Hospital; University of Toronto
Objectives:
At the end of the session, the participants will be able to:
Apply the latest ISUP grading system for prostate cancer in daily practice.
Distinguish Gleason grade 3 patterns from Gleason grade 4 / 5 patterns in prostate needle biopsies.
Identify and report the presence of intraductal carcinoma in prostate needle biopsies.
Recognize unusual variants of prostate cancer in prostate
George Yousef, St. Michael’s Hospital; University of Toronto
Objectives:
At the end of the session, the participants will be able to:
Apply the latest ISUP grading system for prostate cancer in daily practice.
Distinguish Gleason grade 3 patterns from Gleason grade 4 / 5 patterns in prostate needle biopsies.
Identify and report the presence of intraductal carcinoma in prostate needle biopsies.
Recognize unusual variants of prostate cancer in prostate
needle biopsies.
Describe the potential clinical importance of large scale genomic profiling studies in prostate cancer.
Describe the potential clinical importance of large scale genomic profiling studies in prostate cancer.